Login

David Richards, CEO of WANdisco PLC, recently discussed his company's approach to simplifying cloud technology.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Power of Goal Setting & Follow-Through | Don Martin, CFP® - Horizon Advisors
00:10:00
"Driving Inclusive Fintech: Insights from Maelis Carraro of Catalyst Fund | Maelis Carraro - Managing Director, Catalyst Fund"
00:10:00
UBS CEO Sergio Ermotti on Strong Momentum, Strategic Growth, and Market Outlook | Sergio Ermotti , CEO , UBS.
00:10:00
Resilient Real Estate Investing with Integrity and Transparency
00:10:00
Technology and life sciences investment firm that builds and invests in the worlds most ambitious companies|Drew Oetting,Founder,8VC
00:10:00
Ares CEO Calls on Direct Lending and C-Corp Switch | Chairman Harry Yu, CEO, Ares International Corp2471:TAI
00:10:00
The company specializing in cryptoassets|Linda Xie,Co-Founder and Managing Director,Scalar Capital
00:10:00
How to Break Into Venture Capital (VC)|Lindy Morris Fishburne,Managing Partner,Breakout Ventures
00:10:00
Addressing Geopolitical and Economic Influences on Wealth Management Strategies | Andrew Schlossberg , CEO , Invesco.
00:10:00
A diverse and experienced team of founders, geeks and operators who are passionate about the positive impact of tech|Mr. Tarek Asaad, Managing Partner,Algebra Ventures
00:10:00
Compound vs Simple Interest: Understanding the Difference | Mike Murkins - Financial Planner of Syverson Strege
00:10:00
"Strategic Insights for 2024: Goldman Sachs Leaders on Cash, US Assets, and Alternatives"

© 2017 - Neuhu+